COYA TAPIA to Breast Neoplasms
This is a "connection" page, showing publications COYA TAPIA has written about Breast Neoplasms.
Connection Strength
0.266
-
HER2 analysis in breast cancer: reduced immunoreactivity in FISH non-informative cancer biopsies. Int J Oncol. 2004 Dec; 25(6):1551-7.
Score: 0.044
-
Combined inhibition of DDR1 and CDK4/6 induces synergistic effects in ER-positive, HER2-negative breast cancer with PIK3CA/AKT1 mutations. Oncogene. 2021 07; 40(26):4425-4439.
Score: 0.035
-
First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models. Breast Cancer Res. 2021 03 04; 23(1):29.
Score: 0.034
-
Standardization for Ki-67 assessment in moderately differentiated breast cancer. A retrospective analysis of the SAKK 28/12 study. PLoS One. 2015; 10(4):e0123435.
Score: 0.023
-
Negative regulation of NF-?B by the ING4 tumor suppressor in breast cancer. PLoS One. 2012; 7(10):e46823.
Score: 0.019
-
Differential pattern and prognostic significance of CD4+, FOXP3+ and IL-17+ tumor infiltrating lymphocytes in ductal and lobular breast cancers. BMC Cancer. 2012 Apr 03; 12:134.
Score: 0.018
-
Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time. Proc Natl Acad Sci U S A. 2011 Nov 22; 108(47):18879-86.
Score: 0.018
-
Deletion of the inhibitor of growth 4 (ING4) tumor suppressor gene is prevalent in human epidermal growth factor 2 (HER2)-positive breast cancer. Hum Pathol. 2011 Jul; 42(7):983-90.
Score: 0.017
-
Close association between HER-2 amplification and overexpression in human tumors of non-breast origin. Mod Pathol. 2007 Feb; 20(2):192-8.
Score: 0.013
-
HER2 gene status in primary breast cancers and matched distant metastases. Breast Cancer Res. 2007; 9(3):R31.
Score: 0.013
-
Predominance of high-grade pathway in breast cancer development of Middle East women. Mod Pathol. 2005 Jul; 18(7):891-7.
Score: 0.011
-
Prognostic relevance of gene amplifications and coamplifications in breast cancer. Cancer Res. 2004 Dec 01; 64(23):8534-40.
Score: 0.011
-
KIT (CD117)-positive breast cancers are infrequent and lack KIT gene mutations. Clin Cancer Res. 2004 Jan 01; 10(1 Pt 1):178-83.
Score: 0.010